|
C20ORF111 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
1.69250000003895E-06 |
| Normal-vs-Stage3 |
2.36870000003275E-06 |
| Normal-vs-Stage4 |
4.07390000000118E-05 |
| Stage1-vs-Stage2 |
5.578200E-01 |
| Stage1-vs-Stage3 |
1.911650E-02 |
| Stage1-vs-Stage4 |
3.434800E-01 |
| Stage2-vs-Stage3 |
2.288600E-01 |
| Stage2-vs-Stage4 |
7.471000E-01 |
| Stage3-vs-Stage4 |
4.221600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.357020E-03 |
| Normal-vs-Asian |
1.223440E-01 |
| Caucasian-vs-AfricanAmerican |
2.191600E-01 |
| Caucasian-vs-Asian |
8.674400E-01 |
| AfricanAmerican-vs-Asian |
4.978600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.65499999985153E-07 |
| Male-vs-Female |
4.632800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.523200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62725388719309E-12 |
| Normal-vs-Age(61-80Yrs) |
2.53199683442062E-11 |
| Normal-vs-Age(81-100Yrs) |
5.682200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.259370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.463400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.840000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.527400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.075400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.473600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.771530E-02 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
3.60059981829863E-10 |
| Normal-vs-Grade 4 |
2.723100E-03 |
| Grade 1-vs-Grade 2 |
8.893000E-01 |
| Grade 1-vs-Grade 3 |
5.459200E-01 |
| Grade 1-vs-Grade 4 |
4.033400E-01 |
| Grade 2-vs-Grade 3 |
1.548830E-01 |
| Grade 2-vs-Grade 4 |
1.049760E-01 |
| Grade 3-vs-Grade 4 |
4.625800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
2.29940000373574E-09 |
| ccA subtype-vs-ccB subtype |
9.135000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.69029243327168E-12 |
| Normal-vs-N1 |
1.360400E-01 |
| N0-vs-N1 |
6.676600E-01 |
|
|
